Angiotensin-(1–7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats
- 1 January 2011
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 300 (1) , F272-F282
Abstract
Angiotensin (ANG)-(1–7) constitutes an important functional end-product of the renin-angiotensin-aldosterone system that acts to balance the physiological actions of ANG II. In the kidney, ANG-(1–7) exerts beneficial effects by inhibiting growth-promoting pathways and reducing proteinuria. We examined whether a 2-wk treatment with a daily dose of ANG-(1–7) (0.6 mg·kg−1·day−1) exerts renoprotective effects in salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP). Body weight, glycemia, triglyceridemia, cholesterolemia, as well as plasma levels of Na+ and K+ were determined both at the beginning and at the end of the treatment. Also, the weekly evolution of arterial blood pressure, proteinuria, and creatinine clearance was evaluated. Renal fibrosis was determined by Masson's trichrome staining. Interleukin (IL)-6, tumor necrosis factor (TNF)-α, and nuclear factor-κB (NF-κB) levels were determined by immunohistochemistry and confirmed by Western blotting analysis. The levels of glomerular nephrin were assessed by immunofluorescence. Chronic administration of ANG-(1–7) normalized arterial pressure, reduced glycemia and triglyceridemia, improved proteinuria, and ameliorated structural alterations in the kidney of SHRSP as shown by a restoration of glomerular nephrin levels as detected by immunofluorescence. These results were accompanied with a decrease in both the immunostaining and abundance of IL-6, TNF-α, and NF-κB. In this context, the current study provides strong evidence for a protective role of ANG-(1–7) in the kidney.Keywords
This publication has 57 references indexed in Scilit:
- Activation of Protein Kinase C Isoforms and Its Impact on Diabetic ComplicationsCirculation Research, 2010
- Infusion of angiotensin-(1–7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritisAmerican Journal of Physiology-Renal Physiology, 2010
- Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2Hypertension, 2010
- Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal InflammationPLOS ONE, 2009
- Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive ratsPharmacological Research, 2009
- Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitusNephrology Dialysis Transplantation, 2009
- Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cellsNephrology Dialysis Transplantation, 2009
- Attenuation of NADPH Oxidase Activation and Glomerular Filtration Barrier Remodeling With Statin TreatmentHypertension, 2008
- Angiotensin II Infusion Induces Nephrin Expression Changes and Podocyte ApoptosisAmerican Journal of Nephrology, 2008
- The podocyte's response to injury: Role in proteinuria and glomerulosclerosisKidney International, 2006